期刊文献+

星点设计-效应面优化法优化2-(3-羟基-1-金刚烷基)-2-乙醛酸的合成工艺 被引量:5

Optimization of the synthesis process of 2-(3-hydroxy-1-adamantyl)-2-oxoacetic acid by the central composite design-response surface methodology
下载PDF
导出
摘要 采用星点设计-效应面优化法对2-金刚烷基乙醛酸5合成2-(3-羟基-1-金刚烷基)-2-乙醛酸6的因素进行考证,以提高化合物6的收率。以金刚烷甲酸1为起始原料,酰氯化后与丙二酸二乙酯钠盐缩合,脱羧得到乙酰金刚烷4,4经两步高锰酸钾氧化分别得5和6。化合物5到6的氧化反应是关键步骤,通过单因素考察法对化合物5合成6的工艺影响因素进行初步考察,并用星点设计-效应面优化法对显著性因素进行优化和多元线性回归与二项式方程拟合。优化后的化合物4到6的工艺总收率由文献报道的30%~40%提高到57.8%。星点设计-效应面优化法是一种简便、可行的工艺优化方法。 To improve the yield of the compound 6, the method of central composite design-response surface methodology was used to 2-adamantyl glyoxylic acid 5 synthesis 2-(3-hydroxy-l-adamantyl)-2-oxoacetie acid 6. The 5 and 6 was synthesized from adaman- tane formic acid 1 via reaction with dimethyl sulfoxide, diethyl malonate sodium salt and decarboxylation to give acetyl adamantine 4 which was subjected to two step oxidation by potassium permanganate. Because of the process 5 to 6 was a key step, the significant factors method was preliminary utilized to synthesis compound 6 and the central composite design-response surface methodology was to optimize the significant factors and multiple linear regression and binomial equation fitting. Finally, the total yield of 4 to 6 was reached 57.8% from 30%~40%. Central composite design-response surface methodology was a feasible and convenient method.
出处 《化学研究与应用》 CAS CSCD 北大核心 2013年第2期194-199,共6页 Chemical Research and Application
基金 重庆市自然科学基金项目(2006BB5286)资助 重庆医科大学大学生科学研究与创新实验资助项目(201224)资助
关键词 2-(3-羟基-1-金刚烷基)-2-乙醛酸 星点设计-效应面法 工艺优化 2 - ( 3-hydroxy-1 -adamantyl) -2 -oxoacetic acid central composite design-response surface methodology process optimiza-tion
  • 相关文献

参考文献11

  • 1Augeri D J,Robl J A,Betebenner D A. Discovery and preclinical profile of saxagliptin (BMS-477118):a highly potent,long-acting,orally active dipeptidyl peptidase Ⅳ inhibitor for the treatment of type 2 diabetes[J].Journal of Medicinal Chemistry,2005,(15):5025-5037.doi:10.1021/jm050261p. 被引量:1
  • 2Rosenstock J,Sankoh S,List J F. Glucose-lowering activity of the dipeptidyl peptidase-4 inhibitor saxagliptin in drugnaive patients with type 2 diabetes[J].Diabetes,Obesity and Metabolism,2008,(05):376-386. 被引量:1
  • 3Mathias B,Helsinki,Reijo P. Process for the perparation of adamantane derivatives[P].US:7205432,2007. 被引量:1
  • 4Eric.L.williams. Synthesis process for 2-(3-hydroxy-1-amamantyl)-2-oxoacetic acid[P].US:7250529,2007. 被引量:1
  • 5Gloria L Anderson,Winifred A,Winifred A. Burks.Novel synthesis of 3-fluoro-l-aminoadamntzne and some of its derivatives[J].Synthetic Communications,1988,(16-17):1967-1974. 被引量:1
  • 6Pratt D G,Rothstein E. The elimination of carbon monoxide from acid derivatives.part Ⅲ, planar carbonium ions as necessary intermediates[J].Journal of the Chemical Society C:Organic articles,1968.2548-2554. 被引量:1
  • 7Stetter H,Rausher E,Rausher E. Preparation of adamantine methyl ketone[J].Chemische Berichte,1970.863-865. 被引量:1
  • 8Charles W Jefford,Jean-Claude Flossier,John Boukouvalas. Eliminative ring fission of 1, 2, 4-Trioxan-5-ones.a new approach to a-keto acids[J].Journal of the Chemical Society,Chemical Communications,1986.1701-1702. 被引量:1
  • 9Vu Truc Chi,Brzozowski David B,Fox Ritz. Methods and compounds for producing dipeptidyl peptidase Ⅳ inhibitors and intermediates thereof[P].US:7705033,2010. 被引量:1
  • 10Ollie D Godfrey Jr,Rita T Fox,Fredric G Buono. Novel 1,4-homofragmentztion via anr-Lactone[J].Journal of Organic Chemistry,2006.8647-8650. 被引量:1

同被引文献39

  • 1张玉琥.化学药物复方制剂杂质研究的特点及基本思路[J].中国新药杂志,2006,15(16):1327-1329. 被引量:11
  • 2孔黎春.金刚烷二取代衍生物的合成及应用开发研究[D].苏州:苏州大学.2006. 被引量:1
  • 3Mohler M L,He Y,Wu Z,et al. Recent and emerging anti- diabetes targets E J ]. Med Res Rev. 2009,29 ( 1 ) : 125-195. 被引量:1
  • 4Scott A. Savage, Gregory S. Jones, Sergei. Kolotuehin, et al. Preparation of saxagliptin, a novel DPP-IV inhibitor [ J ]- OrgProcess Res Dev,2009,13:l 169-1 176. 被引量:1
  • 5T. C. Vu, D. B. Brzozowski, R. Fox, J. D. Godfrey, et al. Methods and compounds producing dipeptidyl peptidase IV inhibitors and intermediates thereof [ P ]. WO: 2004/ 052850 A2,2004-06-24. 被引量:1
  • 6Ronald L Hanson, Steven L Goldberg, David B Brzozows- ki, et al. Preparation of an amino acid intermediate for the dipeptidyl peptidase IV inhibitor, saxagliptin, using a rood- flied phenylalanine dehydrogenase [ J ]. Adv Syrah Catal, 2007,349:1 369-1378. 被引量:1
  • 7Politino M, Cadin MM, Skonezny PM, et al. Process for preparing dipeptidyl IV inhibitors and intermediates there- for[ P]. WO :2005106011,2005-10-11. 被引量:1
  • 8Eric LW, Zachary LA. Synthesis process for 2-( 3-hydroxy- 1-adamantyl ) -2-oxoacetic acid [ P ]. US: 20060063950.2006-05-23. 被引量:1
  • 9Mathias B, Helsinki, Reijo P. Process for the perparation of adamantane derivatives : [ P]. US : 7205432 2007434-17. 被引量:1
  • 10Stetter, H. ; Rausher, E. Preparation of adamantine methyl ketone[ J]. Chem Ber, 1970,103:863-$65. 被引量:1

引证文献5

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部